S-oxprenolol

S-氧烯洛尔

Report date: 2024/01/29 17:45:40

Base Information

Drug NameS-oxprenolol
Drug Alias NameACM-002FDY 8801
ClassificationSmall molecules
Mechanisms of ActionBeta-1 adrenergic receptor antagonistsBeta-2 adrenergic receptor agonistsSerotonin 1a (5-HT1a) receptor antagonists
TargetsBeta-1 adrenergic receptorBeta-2 adrenergic receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsCachexiaAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesActimed Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFaraday Pharmaceuticals IncActimed Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsCachexiaAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A